Delivery Order SPE2DX22D0010-SPE2D826FCG26
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,807 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under a larger indefinite delivery contract vehicle. The award is part of AmerisourceBergen's...
- This delivery order, awarded on October 20, 2025, represents a $13,413.71 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply provision. The contract, which is a child award under a larger indefinite delivery vehicle, was issued by the Defense Logistics Agency's Medical Supply Chain division and is set to be completed by October 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This delivery order, valued at $5,894.97, was awarded on January 6, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency to support pharmaceutical procurement needs. The award is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations, and the contract has an...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $92,138.57 on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract, issued under a firm fixed-price arrangement with no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying pharmaceutical products and medical commodities to...
- This delivery order, awarded to AmerisourceBergen Drug Corp on January 5, 2026, represents a $65,330.55 firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The work will be performed in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,523.20 on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside contract utilizes firm fixed pricing and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency program. The delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., which...
- This delivery order, awarded on October 14, 2025, represents a $1,639.62 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. The contract utilizes a non-competitive delivery order structure as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,558.13 on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price contract was competitively awarded without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense agency component. The contract represents a child delivery order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- This delivery order, awarded to AmerisourceBergen Drug Corp on December 1, 2025, represents a $114,659.48 firm fixed-price contract for pharmaceutical and medical supply procurement. The award is non-competitive with no set-aside designation and is scheduled for completion by December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under the company's existing Indefinite Delivery...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCG26Delivery Order
This delivery order, awarded on January 7, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) represents a firm fixed-price pharmaceutical supply transaction valued at $1,564.20 with an ultimate completion date of January 8, 2026. The contract was funded by the Defense Logistics Agency's Medical Supply Chain division and executed without a set-aside designation, reflecting open and competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order operates as a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The underlying IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. AmerisourceBergen's consistent performance on federal pharmaceutical contracts demonstrates its capability to efficiently fulfill government requirements across multiple therapeutic domains for military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/6/26 |